(WEBINAR) Benzodiazepines: What a clinician should know
CE Type:*Cert of Attendance Only
# of CE's: Certificate of Attendance only
Certificate of Attendance Only
About This Course
Benzodiazepines (BZ) are commonly prescribed and used medications. While highly effective in relieving anxiety symptoms, they are also popular drugs of use and abuse. This presentation will equip clinicians with an understanding of the pharmacology of BZ and explore patterns of use, intoxication, and withdrawal syndrome as well as describe clinical skills for assessing a client’s use of BZ, and techniques of working with clients who use BZ. Finally, understanding the challenges of individuals with co-occurring disorder and their use of BZ will be discussed.
Learning Objectives:
- Describe the pharmacologic properties of BZ and how they work.
- Describe BZ intoxication and withdrawal syndromes.
- Describe a method of evaluating an individual who is using BZ.
- Describe an approach to helping clients decrease and stop their BZ use.
Intended Audience:
Behavioral health staff working in the drug and alcohol field.
Instructional Level:
Intermediate
Completion Requirements:
Participants must attend the entire session, participate in all activities, and submit an evaluation within the 7 days of training to receive a certificate. All certificates of attendance will be received through the DBHIDS Learning Hub. Once you have completed your evaluation you will have access to your Certificate of Attendance through your DBHIDS Learning Hub Account.
Credit Statements:
Certificate of Attendance Only
Course Instructors
November 10, 2022
Pete DeMaria, Jr.
Coordinator of Psychiatric Services
Tuttleman Counseling Services at Temple University
M.D., FASAM, DFAPA
Dr. DeMaria is the coordinator of psychiatric services of the Tuttleman Counseling Services at Temple University in Philadelphia, and clinical professor of psychiatry and behavioral sciences. at the Lewis Katz School of Medicine at Temple University. Prior to coming to Temple, he was the medical director of the Narcotic Addict Rehabilitation Program of Thomas Jefferson University and an associate professor of psychiatry and human behavior at Jefferson Medical College (now the Sidney Kimmel Medical School). He also served as psychiatric consultant at Jefferson’s Family Center Program, a program for addicted pregnant and parenting women. Board certified in general psychiatry, addiction psychiatry, and addiction medicine, Dr. DeMaria is a fellow of the American Society of Addiction Medicine (ASAM). He is a distinguished fellow of the American Psychiatric Association. In October 2001, he received the Nyswander- Dole Award from the American Methadone Treatment Association (now the American Association for the Treatment of Opioid Dependence) for his outstanding service in the methadone treatment field.
April 13, 2023
Pete DeMaria, Jr.
Coordinator of Psychiatric Services
Tuttleman Counseling Services at Temple University
M.D., FASAM, DFAPA
Dr. DeMaria is the coordinator of psychiatric services of the Tuttleman Counseling Services at Temple University in Philadelphia, and clinical professor of psychiatry and behavioral sciences. at the Lewis Katz School of Medicine at Temple University. Prior to coming to Temple, he was the medical director of the Narcotic Addict Rehabilitation Program of Thomas Jefferson University and an associate professor of psychiatry and human behavior at Jefferson Medical College (now the Sidney Kimmel Medical School). He also served as psychiatric consultant at Jefferson’s Family Center Program, a program for addicted pregnant and parenting women. Board certified in general psychiatry, addiction psychiatry, and addiction medicine, Dr. DeMaria is a fellow of the American Society of Addiction Medicine (ASAM). He is a distinguished fellow of the American Psychiatric Association. In October 2001, he received the Nyswander- Dole Award from the American Methadone Treatment Association (now the American Association for the Treatment of Opioid Dependence) for his outstanding service in the methadone treatment field.